TET2 LOF mutations were found in ~20% of MDS patients, ~20% of myeloproliferative neoplasms (MPN), ~20% of AML, and ~45% of chronic myelomonocytic leukemia (CMML). The gene discussed is TET2; the disease is myeloproliferative neoplasm.